HTR2B and congenital bilateral aplasia of vas deferens from CFTR mutation: Based on results from the mutant study, we aimed to determine if the beneficial effects of Htr2b ablation on CAVD progression could be recapitulated using a pharmacological inhibitor specific to the 5-HT2B receptor.